Jordan Schultz, PharmD, University of Iowa Health Care (IMAGE)

University of Iowa Health Care

Jordan Schultz, PharmD, University of Iowa Health Care

Caption

Jordan Schultz, PharmD, and his team at University of Iowa Health Care, found that beta-blocker usage is associated with delayed onset and slower disease progression in Huntington's disease.

Credit

University of Iowa Health Care

Usage Restrictions

May be used with appropriate credit for informational and educational purposes.

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.